Company intelligence / Profile preview
MAK Scientific Management
Boston, Massachusetts, United Statesmakscientific.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
MAK Scientific is a biotechnology company focused on the discovery and development of small molecule therapeutics targeting the endocannabinoid system. The company leverages its expertise in medicinal chemistry and pharmacology to create modulators of cannabinoid receptors and enzymes involved in endocannabinoid metabolism, such as FAAH and MAGL. Their research aims to address significant unmet medical needs in chronic pain, inflammation, and metabolic disorders. MAK Scientific operates primarily through a collaborative model, often working with academic institutions to advance its early-stage pipeline.
- Therapeutic areas
- PsychiatryImmunologyNeurologyMetabolic Disorders
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on MAK Scientific Management.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MAK Scientific Management.